Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020). Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nature Portfolio.
Cita Chicago Style (17a ed.)Charbonneau, Mark R., Vincent M. Isabella, Ning Li, y Caroline B. Kurtz. Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases. Nature Portfolio, 2020.
Cita MLA (8a ed.)Charbonneau, Mark R., et al. Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.